TW201642904A - 含抗ｆｇｆｒ２抗體及其他藥劑之組成物 - Google Patents

含抗ｆｇｆｒ２抗體及其他藥劑之組成物 Download PDF

Info

Publication number
TW201642904A
TW201642904A TW105110850A TW105110850A TW201642904A TW 201642904 A TW201642904 A TW 201642904A TW 105110850 A TW105110850 A TW 105110850A TW 105110850 A TW105110850 A TW 105110850A TW 201642904 A TW201642904 A TW 201642904A
Authority
TW
Taiwan
Prior art keywords
combination
antibody
composition
contained
amino acid
Prior art date
Application number
TW105110850A
Other languages
English (en)
Chinese (zh)
Inventor
鹽瀨能伸
石田佐央里
Original Assignee
第一三共股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 第一三共股份有限公司 filed Critical 第一三共股份有限公司
Publication of TW201642904A publication Critical patent/TW201642904A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/282—Platinum compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
TW105110850A 2015-04-08 2016-04-07 含抗ｆｇｆｒ２抗體及其他藥劑之組成物 TW201642904A (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2015079468 2015-04-08

Publications (1)

Publication Number Publication Date
TW201642904A true TW201642904A (zh) 2016-12-16

Family

ID=57072444

Family Applications (1)

Application Number Title Priority Date Filing Date
TW105110850A TW201642904A (zh) 2015-04-08 2016-04-07 含抗ｆｇｆｒ２抗體及其他藥劑之組成物

Country Status (3)

Country Link
JP (1) JP6887944B2 (ja)
TW (1) TW201642904A (ja)
WO (1) WO2016163433A1 (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202342527A (zh) * 2022-02-25 2023-11-01 美商安進公司 鱗狀非小細胞肺癌之治療

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2365828T3 (en) * 2008-11-07 2014-12-08 Galaxy Biotech Llc Monoclonal antibodies against fibroblast second
RU2012153241A (ru) * 2010-05-11 2014-06-20 Авео Фармасьютикалз, Инк. Антитела к fgfr2
AR088941A1 (es) * 2011-11-23 2014-07-16 Bayer Ip Gmbh Anticuerpos anti-fgfr2 y sus usos
SG10201608382QA (en) * 2012-04-09 2016-12-29 Daiichi Sankyo Co Ltd Anti-fgfr2 antibody
JP6509735B2 (ja) * 2013-10-08 2019-05-08 第一三共株式会社 抗ｆｇｆｒ２抗体と他剤の組合せ

Also Published As

Publication number Publication date
WO2016163433A1 (ja) 2016-10-13
JPWO2016163433A1 (ja) 2018-02-22
JP6887944B2 (ja) 2021-06-16

Similar Documents

Publication Publication Date Title
EP2844675B1 (en) Humanized pan-her antibody compositions
JP6124377B2 (ja) 新規抗ｄｒ５抗体
KR102005308B1 (ko) 암의 치료 및/또는 예방용 의약 조성물
EP3842072A1 (en) Anti-ror1 antibodies
KR20190140945A (ko) NRG1 융합 유전자를 가지는 세포를 치료하기 위한 ErbB-2 및 ErbB-3 결합 이중특이적 항체
AU2019242520A1 (en) Pharmaceutical composition for treatment and/or prevention of cancer
KR20180081606A (ko) 암 치료에서의 단독의, 또는 면역 자극제와 병용한, fgfr2 억제제
KR20140130668A (ko) 암의 치료 및/또는 예방용 의약 조성물
KR20220152318A (ko) 암의 치료 및/또는 예방을 위한 의약품
EP3831412A1 (en) Treatment of metastatic brain tumor by administration of antibody-drug conjugate
US20220289825A1 (en) FUSION PROTEIN TARGETING PD-L1 AND TGF-ß AND USE THEREOF
JP6887944B2 (ja) 抗ｆｇｆｒ２抗体と他剤を含む組成物
KR20220153615A (ko) 암의 치료 및/또는 예방을 위한 의약품
KR20220152309A (ko) 암의 치료 및/또는 예방을 위한 의약품
KR20220151684A (ko) 암의 치료 및/또는 예방을 위한 의약품
KR20220153621A (ko) 암의 치료 및/또는 예방을 위한 의약품
TW201716439A (zh) Ｈｅｒ３抗體
RU2781542C2 (ru) Фармацевтическая композиция для лечения и/или профилактики злокачественной опухоли
WO2022075482A1 (ja) がん治療用医薬
WO2022270523A1 (ja) 癌の治療及び／又は予防のための医薬品
EP4180457A1 (en) Anti-cldn-18.2 antibody and use thereof
US20230293714A1 (en) Combination of anti-her2 antibody-drug conjugate with her dimerization inhibitor
KR20240024803A (ko) 암의 치료 및/또는 예방을 위한 의약품
WO2023218378A1 (en) Combination of an antibody specific for a tumor antigen and a cd47 inhibitor
JP2021107384A (ja) 部位特異的ｈｅｒ２抗体薬物コンジュゲートを用いた処置